- MyIllumina
- Tools
The HumanLinkage V Panel Set is optimized to detect recombination events. Linkage analysis is a powerful approach for mapping the location of disease-causing loci. The likelihood of a recombination event occurring between two markers is related to the distance between them. Markers closest to a disease gene will co-segregate most strongly with the disease phenotype.
The panel's 6,056 SNP markers were chosen from highly validated HapMap DNA assays to optimize information content, enabling researchers to extract the greatest amount of data from the least number of markers. Every SNP marker has been robustly validated for physical and genetic map positions, distances, and unique sequence identification.
Catalog IDs: GT-17-240
View the product support page for additional technical information ยป
Innovative technologies
At Illumina, our goal is to apply innovative technologies and revolutionary assays to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. These studies will help make the realization of personalized medicine possible. With such rapid advances in technology taking place, it is mission critical to have solutions that are not only innovative, but flexible, scalable, and complete with industry-leading support and service. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and prioritizing the needs of its customers, we strive to meet this challenge. Illumina's innovative, array-based solutions for DNA, RNA, and protein analysis serve as tools for disease research, drug development, and the development of molecular tests in the clinic.
At Illumina, our goal is to apply innovative technologies and revolutionary assays to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. These studies will help make the realization of personalized medicine possible. With such rapid advances in technology taking place, it is mission critical to have solutions that are not only innovative, but flexible, scalable, and complete with industry-leading support and service. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and prioritizing the needs of its customers, we strive to meet this challenge. Illumina's innovative, array-based solutions for DNA, RNA, and protein analysis serve as tools for disease research, drug development, and the development of molecular tests in the clinic.
© 2012 Illumina, Inc. All rights reserved.